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Apoptotic cell clearance facilitates the removal of aged, damaged, infected or dangerous cells although minimizing perturbation
of surrounding tissues, and is a vital process in the development and homeostasis of multicellular organisms. Importantly,
failure to correctly execute programmed cell death and subsequent corpse clearance is broadly associated with chronic
inﬂammatory and/or autoimmune diseases such as systemic lupus erythematosus. Apoptotic cells develop dramatic
morphological changes including contraction, membrane blebbing and apoptotic body formation, which were among the ﬁrst
and most readily identiﬁable features of cellular suicide. However, understanding the purpose of apoptotic cell morphological
changes has proven to be elusive, and recent studies have made somewhat surprising, and occasionally opposing, conclusions
about the contribution of blebbing to phagocytic clearance and prevention of inﬂammatory/autoimmune disease. We review the
evidence indicating how apoptotic blebs actively promote corpse recognition, uptake, and generation of auto-reactive
antibodies.
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Facts
  Actomyosin contraction provides the force-driving contrac-
tion, membrane blebbing and apoptotic body formation
during programmed cell death.
  Apoptotic cells display cell surface markers that facilitate
recognition and uptake by phagocytic cells.
  Impaired apoptotic cell clearance may contribute to
inﬂammation and autoimmunity.
Open Questions
  How are apoptotic cell surface markers concentrated on
blebs?
  How do markers such as calreticulin and N-acetylglucosa-
mine come to be displayed on the surface of apoptotic
cells?
  Whatistheroleofblebbingintherecognitionandclearance
of apoptotic cells?
Actomyosin Contraction Drives Apoptotic Blebbing
Apoptotic cells can often be discriminated from viable
counterparts based on several morphological hallmarks
including highly conspicuous nuclear condensation and
fragmentation, and frequent appearance of characteristic
plasma membrane blebs (Figure 1a). Blebs are balloon-like
protrusive blisters formed when cellular plasma membrane
delaminates from the cortical cytoskeleton, and which can be
retracted and reformed in a dynamic cycling process covering
theentiresurfaceofapoptoticcells.Theformationofapoptotic
blebs is a physical process that results from increased
hydrostatic pressure following actomyosin-mediated cellular
contraction.
1,2 When newly formed, blebs are devoid of actin
and other cytoskeletal proteins. Subsequently, an actin cortex
rapidly polymerizes within the protruding bleb, followed by the
recruitment of cytoskeletal bundling proteins and myosin that
then power bleb retraction.
3 In apoptotic cells this cyclic
process of bleb formation and retraction can occur over
sustained periods, and as programmed cell death progresses
blebs may become packed with cellular organelles and
condensed chromatin to form the basis of fragmentary
membrane-clad apoptotic bodies (Figure 1a).
4 However, it
should be noted that apoptotic blebbing is not a universal
feature of programmed cell death, some cell types do not
appear to generate membrane blebs nor undergo fragmenta-
tion.
5 Nonetheless, blebbing is a very common feature
of apoptotic cells and has become a morphological hallmark
of programmed cell death.
In 2001, it was discovered that apoptotic blebbing is
dependent upon activity of the actomyosin regulator ROCK1
kinase.
6,7 Moreover, it was apparent that apoptotic ROCK1
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www.nature.com/cddactivation is independent of its canonical activator
Rho GTPase. This atypical form of ROCK activation was
associated with caspase cleavage of ROCK1, but not
ROCK2, after a conserved site within the C-terminus
(1110DETD1113)
6 (Figure 1b). Further investigation revealed
that caspase cleavage of ROCK1 yields a constitutively active
kinase fragment that is sufﬁcient to induce membrane
blebbing resembling that seen in apoptotic cells. In addition,
the cleaved ROCK1 fragment appears to be important for
disruption of nuclear integrity and the packaging of fragmen-
ted DNA into membrane blebs and apoptotic bodies.
4,6 Thus,
the generation of constitutively active ROCK1 kinase frag-
mentsappears to bean important mechanism tocomplete the
execution phase of cellular apoptosis. When cell death has
been triggered by extrinsic factors such as TNFa, ceramide or
Fas-receptor ligation, ROCK1 cleavage and activation are
relatively late events,
6,7 consequently ROCK inhibition does
not halt the apoptotic process.
6 However, in some contexts
chronic or high-intensity ROCK activity may contribute to the
initiation of apoptosis. Data from ROCK1 knockout mice
revealed that blood pressure overload was less effective at
inducing cardiomyocyte apoptosis compared with control
wild-type mice, suggesting a potential role for ROCK1
activation in myocardial failure.
8 Although ROCK1 cleavage
and activation is associated with the formation of apoptotic
blebs, and ROCK activity is necessary for blebbing, formal
proof of the absolute requirement for ROCK1 cleavage as
the causal event leading to apoptotic blebbing remains to be
provided. Although ROCK2 is not cleaved by caspases and is
therefore unlikely to be involved in apoptotic blebbing induced
by conventional intrinsic and extrinsic stimuli, it can be
cleaved by granzyme B,
9 a serine protease injected into
target cells by cytotoxic T-cells and natural killer cells to
induce cell death by mitochondrial disruption and caspase 3
cleavage and activation.
10 Interestingly, granzyme B cleaves
ROCK2 analogously to caspase 3 cleavage of ROCK1;
ROCK2 cleavage after D1131 releases the C-terminal
autoinhibitory domain leading to constitutive kinase domain
activation capable of inducing membrane blebs.
9 Due to the
activation of caspase 3 during granzyme B-induced apopto-
sis, ROCK1 cleavage also occurs, thus the relative contribu-
tion of ROCK2 cleavage towards the formation of apoptotic
blebs remains unclear. Furthermore, as ROCK2 is not
cleaved during apoptosis induced by conventional signals,
thepost-translationalmodiﬁcationthatproducesconstitutively
active ROCK2 appears not to be generally required for
apoptotic blebbing.
AlthoughROCK1cleavageisapparentlyvitalforblebbing,it
seems dispensable for many other apoptotic phenomena
including caspase activation, phosphatidylserine (PS) exter-
nalization, and poly ADP-ribose polymerase cleavage.
6,7,11
This leaves open the question of precisely what the purpose
ofROCK1 cleavage,and byextensionmembrane blebbing, in
apoptosis might be.
Apoptotic Cell Recognition
Programmedcelldeath,orapoptosis,isvitalfortheremovalof
problematic or unnecessary cells in multicellular organ-
isms.
12,13 First deﬁned in 1972,
14 apoptosis is an active
process that ultimately concludes with the ﬁnal act of cellular
disposal in which phagocytic cells ingest cellular corpses
and associated debris, a process termed efferocytosis. As a
testament to the efﬁciency and rapidity of efferocytosis, it is
surprisingly difﬁcult to histologically detect apoptotic cells
despite 410
9 cellular suicides occurring per day in adult
tissues.
15,16 There are several broadly deﬁned phases
of phagocytic clearance of apoptotic cells: (1) Find-me,
characterized by the release of soluble signals that attract
macrophages to the dying cell; (2) Eat-me, in which a
phagocyte becomes stimulated by engaging with signals
expressed on the apoptotic cell membrane; (3) Engulfment, a
series of cytoskeletal modiﬁcations in the phagocyte enabling
it to take up the dead cell; (4) Processing, digestion of the
cellular remains through lysosomal degradation.
17–19
Importantly, apoptotic cells actively participate in the initial
phases by displaying signiﬁcant modiﬁcations to their mem-
branes (which can include lipids, proteins and modiﬁed
carbohydrates) that are important aids to recognition and
uptake.Thebestcharacterizedoftheseexternalizedfactorsis
PS, which is normally conﬁned to the inner leaﬂet of the
plasma membrane.
20 During early apoptosis membrane
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Figure 1 Apoptotic blebbing and ROCK1 cleavage. (a) Representative
scanning electron micrograph of apoptotic mouse embryonic ﬁbroblast (MEF) with
many surface blebs (left panel). Representative confocal image of apoptotic MEF
with multiple blebs containing condensed chromatin (right panel, white arrows).
Chromatin is stained with DAPI (blue) and cellular membrane is stained with lipid
dye DiO (G¼green). (b) Schematic of ROCK cleavage by caspase 3 at D1113.
Cleavage yields a constitutively active kinase responsible for apoptotic blebbing.
6
RBD, Rho-binding domain; PH, pleckstrin homology; C1, cysteine rich domain
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Cell Death and Differentiationasymmetry is lost; PS becomes externalized and serves
as a major factor for apoptotic cell recognition (Figure 2a).
A protein that mediates PS externalization was recently
identiﬁed as the eight transmembrane spanning Transmem-
brane Protein 16F (TMEM16F).
21 Externalized PS can be
boundbymilkfatglobuleepidermalgrowthfactor8(MFG-E8),
which tethers the phospolipid to integrin avb3 and/or avb5
expressed on macrophages and monocytes (Figure 2a).
22
Alternatively, PS can be recognized directly by one or more
receptors expressed on macrophages, including; Bai1, Tim5,
and Stabilin2 (Figure 2).
12 PS externalization has also been
detectedonviablecellsinsomeinstances,suggestingthatPS
exposure alone may be insufﬁcient to trigger phagocytosis
and that additional signals are necessary.
23,24 In fact,
enforced PS externalization induced by expression of active
TMEM16F did not induce engulfment by macrophages in vitro
or by dendritic cells (DCs) in vivo.
21 Therefore, it has been
proposed that the ‘Eat-me’ signal received by phagocytes
must be above a threshold level to initiate efferocytosis.
25 The
strengthofsuchasignalcouldbeaugmentedbythebindingof
additional ‘Eat-me’ molecules, such as MFG-E8.
11 Alterna-
tively, spatial concentration of PS or other ‘Eat-me’ molecules
on apoptotic cell membranes may also serve as phagocytic
triggers that focally surpass the required threshold (discussed
below).
25 In addition to PS externalization, apoptotic cells
have further modiﬁcations to their membrane constituents.
The release and dissociation of sub-cellular membrane clad
particles called apoptotic bodies results in bulk membrane
loss that must be replaced from intracellular organelles such
as the Golgi or endoplasmic reticulum.
26 This scavenging of
intracellular membranes leads to the externalization of protein
and glycan groups, including calreticulin and N-acetylgluco-
samine (GlcNAc), that are normally expressed only on
intracellular membranes and which appear to be important
for efferocytosis (Figure 2a).
27,28 Externalization of GlcNAc is
recognized as a determinant of apoptotic thymocyte phago-
cytosis while calreticulin binds complement C1q and aids
phagocytosis of apoptotic cells (Figure 2a).
27,29,30 Moreover,
many of the externalized proteins are modiﬁed by cleavage,
likely by activated caspases, which might easily affect their
function and/or recognition.
31 The atypical externalization of
intracellular material contributes to apoptotic cell-associated
molecular patterns (ACAMP), which either alone or in
conjunction with plasma proteins such as MFG-E8, comple-
ment C1q, mannose-binding lectin and surfactant protein
A are then recognized by macrophages to promote
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Figure 2 Blebs focalize factors that promote clearance. (a) Illustration of an apoptotic cell in complex with a macrophage. Apoptotic cell (green) externalizes multiple
factors including phosphatidylserine, intracellular proteins and glycan groups. These externalized factors can bind serum proteins C1q and MFG-E8. These membrane
modiﬁcations enable rapid clearance by acting as ‘Eat-me’ signals for surveilling macrophages (Mø,yellow), thus maintaining tissue homeostasis. (b) 3 dimensional confocal
reconstruction andvolumetric renderingof apoptoticmouse embryonicﬁbroblast(MEF). Cellularmembraneisstained with lipid dye DiO (green), nucleusis stained with DAPI
(blue), and cell is stained with human complement C1q (red)
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25,29,32,33 The binding of a macrophage to a target
apoptotic cell creates an engulfment synapse and the diverse
molecular interactions between ACAMP and macrophages
initiate important phases of efferocytosis, such as binding and
engulfment.
34–36
Apoptotic Blebbing: promoting Cell Clearance?
A number of studies have attempted to deﬁne the role of
blebbing inapoptotic clearance and revealed somepotentially
contradictory roles for blebs and apoptotic bodies. Several
in vitro studies reported that inhibition of apoptotic blebbing
signiﬁcantly impaired corpse clearance by monocytes and
macrophages.
5,11,28 Further investigation revealed that im-
paired corpse clearance following defective blebbing could be
rescued by the PS-bridging protein, MFG-E8.
11 The implica-
tions of these studies are two-fold: ﬁrstly, apoptotic blebbing
directly inﬂuences efferocytosis; and secondly, PS externali-
zation may be a mechanism linking blebbing and phagocy-
tosis. Although the apoptotic externalization of PS appears to
be ROCK-independent, its sub-cellular localization is ROCK-
dependent.
6,11 In fact, microscopic analysis revealed that
apoptotic blebs become highly enriched for the externalized
phospholipids.
37 Thus, it appears that apoptotic blebs serve
as focal points for accumulation of externalized PS, which is
then recognized by macrophages to trigger engulfment. The
possibility that apoptotic blebs provide topological context for
macrophage recognition is consistent with data demonstrat-
ing PS exposure on viable cells is insufﬁcient to trigger
phagocytosis. Surprisingly, MFG-E8 failed to further enhance
the in vitro phagocytic uptake of normal blebbing apoptotic
cells,
11 suggesting that apoptotic blebbing and subsequent
PS concentration on blebs is sufﬁcient to trigger corpse
clearance in the absence of additional extracellular factors.
When blebbing is impaired, efferocytosis can be rescued by
bridging molecules like MFG-E8; thus there appears to be
redundancy in clearance mechanisms. Such redundant
compensating mechanisms may explain why several geneti-
cally modiﬁed mice with defective clearance mechanisms
are neither developmentally lethal nor display severe auto-
immune phenotypes (if displayed at all), as measured by
survival and overall health. In addition to serving as organiza-
tional centers for PS externalization, apoptotic blebs are
associated with additional membrane modiﬁcations. One of
the most striking examples highlighting the potential impor-
tance of apoptotic blebs is their robust opsonization with
complement C1q in human endothelial cells (Figure 2b).
38,39
The high-density opsonization on the surface of apoptotic
blebs would be expected to efﬁciently trigger efferocytosis by
activating speciﬁc complement receptors such as CD91
expressed by macrophages.
29,40,41 Although the binding of
C1q to apoptotic cells appears to be important for recognition
and clearance, clearance is not dependent on further
activation of the complement cascade.
42 The importance of
this mechanism for triggering clearance is underscored by the
autoimmune disorders observed in C1q-deﬁcient mice.
43
Thus, ROCK-mediated actomyosin contraction, consequent
membrane blebbing and focalized accumulation of ‘Eat-me’
factors might be expected to facilitate rapid efferocytosis
and thus maintain self-tolerance.
Apoptosis, Clearance and Autoimmunity
The execution phase of apoptosis and subsequent corpse
clearance convey powerful anti-inﬂammatory signals to
engulﬁng cells and, importantly, enable apoptotic cells to
remain immunologically silent.
44–46 Furthermore, apoptotic
cell engulfment helps induce a tolerogenic response and
facilitates proteins to be appropriately recognized as ‘self’,
thus avoiding activation of adaptive immunity towards
apoptotic material.
47 Collectively, the combination of rapid
apoptotic cell clearance linked to suppression of immune
activation allows apoptosis to proceed rapidly and efﬁciently
with minimal collateral damage to maintain tissue homeo-
stasis. One of the key features of apoptotic cells that allows
for the rapid and stealthy removal of cellular fragments is a
stable intact membrane (detectable by the exclusion of
impermeable dyes such as propidium iodide) that prevents
release of intracellular proteins and consequent immunologi-
cal activation.
48 This is in contrast to necrotic cell
death, wherein cells inappropriately lyse and release their
intracellular contents leading to rapid pro-inﬂammatory
responses.
45,49 Secondarily necrotic cells release ‘alarmins’,
of which high-mobility group protein B1 (HMGB1) is the
archetype, thatare recognized asdanger signals and provoke
innateimmunecellsintoapro-inﬂammatorystate(Figure3).
50
For this reason, defects in efferocytosis are believed to cause
inappropriate pathological inﬂammation leading to the devel-
opment of autoimmune diseases. Indeed, genetically mod-
iﬁed mouse models in which genes for vital elements of cell
recognition and clearance machinery such as compliment
C1q or MFG-E8 have been deleted display an autoimmune
phenotype resembling systemic lupus erythematosus (SLE).
SLE is a chronic systemic autoimmune disease that affects
multiple organ systems including joints, skin, lymph and
kidneys in nearly 5 million people globally, 90% of whom are
female.
51 The disease is characterized by the generation of
auto-reactive antibodies (particularly against nuclear
antigens), the formation of antibody immune complexes and
pro-inﬂammatory cytokine production.
52,53 Animal models
with defective efferocytosis develop a similar age- and sex-
dependent pathology as seen in human sufferers, associated
with the presence of anti-nuclear antibodies (ANA), spleno-
megaly and glomerulonephritis.
43,54 Although the pathophy-
siology of SLE is multifactorial, the best-deﬁned abnormality
associated with the disease is defective apoptotic cell
clearance. Not only are macrophages from SLE patients
deﬁcient inautologous efferocytosis in vitro,but the numberof
tingible body macrophages that are responsible for the
ingestion of apoptotic corpses in lymphoid tissue germinal
centers are frequently reduced in SLE sufferers.
55,56 Con-
sistent with these observations, SLE is associated with
elevated circulating apoptotic bodies and an accumulation of
apoptotic cells in lymph node germinal centers.
57,58 Further-
more, compliment C1q deﬁciency, which is associated with
increased undigested apoptotic debris, is a potent trigger for
SLE.
59 The increase in free uningested apoptotic debris likely
contributes to the induction of ANAs, which is a classic
diagnostic feature of SLE. Overcoming self-tolerance is a
pathological process closely associated with failed efferocy-
tosis that results in immune activation towards intracellular
Apoptotic cell clearance
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Cell Death and Differentiationmaterial, including nuclear proteins and DNA. Supporting this
possibility, SLE-associated ANAs can be speciﬁc for novel
epitopes produced only after enzymatic modiﬁcations such as
caspase-mediated cleavage.
60 Furthermore, these autoreac-
tive antibodies are somatically mutated IgG isotypes suggest-
ing that they are products of B-cell afﬁnity maturation and thus
the result of an antigen-driven immune response.
61,62
The generation of self-reactive antibodies appears to be
linked to phagocytosis of apoptotic debris by professional
antigen-presenting DCs.
63 DC are potent stimulators of
adaptive immune responses and in an inﬂammatory context
present peptides generated from apoptotic proteins and
potently stimulate immune responses consistent with the
generation of self-reactive antibodies (Figure 3).
64 In fact,
the ingestion of secondarily necrotic apoptotic bodies by
DC is vital for their maturation leading to expression of
co-stimulatory molecules necessary for adaptive immunity.
64
These features of DC make them likely candidates to mediate
auto-antibody generation following phagocytosis of apoptotic
debris accumulated due to failed efferocytosis and further
suggests that additional signals associated with secondary
necrosis, such asHMGB1release, are important components
in the development of autoimmunity.
65,66 Moreover, the
ingestion of apoptotic bodies by DC can stimulate the release
of pro-inﬂammatory cytokines, such as interleukin-6 (IL-6),
thereby inducing auto- and paracrine signaling loops favoring
the generation of auto-reactive antibodies.
64,67–69 Once an
auto-reactive antibody is produced, it would be expected to
opsonize apoptotic cells and potentially encourage inap-
propriate inﬂammatory responses leading to the development
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(e.g. HMGB-1)
DC
Alarmins
(e.g. HMGB-1)
Inflammatory
Mø Inflammatory
Cytokines
(e.g. IL-6)
DC
Alarmins
(e.g. HMGB-1)
Auto-reactive
IgG Inflammatory
Mø Inflammatory
Cytokines
(e.g. IL-6)
Secondary
Necrosis
Inflammation
Antigen
Presentation
Auto-immune
disease
1
3 2
4
nuclear auto-antigen
(Ro, La)
nucleosome
C1q
MFG-E8
Phosphatidyl serine
Figure3 Schematicillustrationoffailedefferocytosisleadingtoauto-immunedisease.Failuretoclearapoptoticcellsleadstosecondarynecrosisandtheeventualrelease
ofalarminssuchasHMGB-1(panel1,topleft).Thesecondarilynecroticcelltriggersthereleaseofpro-inﬂammatorycytokinesbyHMGB-1stimulationofmacrophages(Mø)or
following phagocytosis by DCs. (panel 2, bottom-left panel). In the inﬂammatory context, DCs present ingested apoptotic protein and express co-stimulatory molecules
triggeringBandT-cellactivationleadingtotheproductionofauto-reactiveantibodies(IgG)(panel3,bottomright).Auto-reactiveantibodiesopsoniseapoptoticcellsandtrigger
further inﬂammatory responses characteristic of auto-immune disease (panel 4, top right)
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Cell Death and Differentiationof auto-immune/inﬂammatory diseases such as SLE
(Figure 3).
70 Although auto-immune diseases resulting from
failed efferocytosis are clearly multifactorial, apoptotic bleb-
bing appears to lie at foundational stages of disease onset.
Although apoptotic blebs certainly accumulate a collection
of important ‘Eat-me’ factors such as PS and C1q, they also
appear to be rich in auto-antigens frequently associated with
autoimmune disorders such as SLE. In particular, apoptotic
blebs and discrete apoptotic bodies display many nuclear
auto-antigens such as DNA, nucleosomes, Ro and La
(Figure 4).
25,26,71,72 The implication of these observations is
that blebs and apoptotic bodies are reservoirs of antigens that
may contribute to the generation of auto-immune disease.
63
As previously mentioned, self-tolerance can be challenged by
DC uptake of apoptotic cells. Apoptotic blebbing appears to
participate in this process as DC prefer smaller apoptotic
body-sized cell remnants that are rich in potential auto-
antigens. Furthermore, the ingestion of this material can
stimulateproductionofthepro-inﬂammatorycytokineIL-6and
induce DC maturation.
64,68 The uptake of antigen-rich
apoptotic bodies by DC coupled with the subsequent release
of inﬂammatory mediators and cellular maturation appears to
driveadaptiveimmunityleadingtoauto-immunity(Figure4).
64
Because of these observations, inhibition of apoptotic bleb-
bing has been proposed as a potential therapy to avoid or
attenuate auto-immune disease severity.
70 In fact, inhibition
of blebbing with the ROCK selective inhibitor Y27632 not
only impaired DC phagocytosis of apoptotic bodies
but completely abolished enhanced uptake following
auto-antibody opsonization.
70
Theseobservationsunderscoretheimportanceofapoptotic
cell clearance in the maintenance of self-tolerance. However,
it is important to note that apoptotic clearance failure in itself
may be insufﬁcient to promote auto-immune disease; in fact,
mannose-binding lectin-deﬁcient mice have demonstrated
apoptotic clearance defects without autoimmunity.
73 This
suggests that determinants, in addition to clearance, partici-
pate in the immunological processing of apoptotic cell debris.
It has been proposed that immunosuppressive transforming
growth factor b (TGF-b) release stimulated by binding of
apoptotic cells to macrophages may be sufﬁcient to avoid
potentially problematic auto-antibody generation, even in the
absence of clearance.
16 Nonetheless, defective cell clear-
ance, resulting from impairment or elimination of the myriad
components of efferocytosis, is undoubtedly linked to auto-
immune disease as well as several other disorders in human
and mice including atherosclerosis, neuropathy, arthritis, and
anemia.
12,74
Collectively, these studies indicate that apoptotic blebbing,
as a mechanism to promote cell clearance, is a double-edged
sword. Although blebs appear to be important for rapid uptake
and clearance to maintain homeostasis, simultaneously they
also are sources of auto-antigens (Figure 4). It appears that
the same material recognized by macrophages to trigger
clearance may also be recognized byother cell types, such as
DCs, to generate auto-immune antibodies. The mechanisms
that may lead to these opposing outcomes is currently
unclear; however, defects in macrophage uptake or increases
in apoptosis appear to be important determinants. Hypothe-
tically, the accumulation of apoptotic debris would likely lead
to increased probability of DC activation and, over time, this
inappropriate activation would overcome self-tolerance and
lead to the generation of auto-reactive antibodies character-
istic of autoimmunity. Although the linkage between apoptotic
blebbing and autoimmune disease has been inferred,
there has been no deﬁnitive demonstration of the importance
of apoptotic blebbing in vivo. To date, studies investigating
apoptotic blebbing in the context of clearance and
auto-immune disease have been largely limited to in vitro
experimentation that cannot recapitulate the complexity of
interactions between apoptotic cells and their environment.
Furthermore, these studies may also be compromised by
certain aspects of their experimental design that could affect
outcomes in subsequent assays, such as their dependence
on chemical inhibitors to interfere with apoptotic blebbing, and
extensive washing steps that might alter the stability and
structure of the apoptotic cells. As a result, many of the
observations from in vitro studies regarding the possible
inﬂuence of blebbing towards apoptotic cell clearance and
consequently on the development of autoimmune disease are
potentially compromised. Ultimately clear determination of
the role that apoptotic blebs have in cell clearance and/or the
generation of autoimmune disease will require an in vivo
model of defective blebbing.
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Figure 4 Apoptotic blebs are repositories of membrane modiﬁcations.
Illustration of apoptotic cell with numerous blebs concentrating ‘Eat-me’ signals
as well as nuclear auto-antigens. The relative importance of apoptotic blebs
for efﬁcient efferocytosis and consequent maintenance of homeostasis versus
the presentation of nuclear autoantigens to DCs leading to the development
of autoimmunity is unclear, and likely awaits the development of in vivo models
deﬁcient in apoptotic blebbing
Apoptotic cell clearance
G Wickman et al
740
Cell Death and Differentiation1. Charras GT, Coughlin M, Mitchison TJ, Mahadevan L. Life and Times of a Cellular Bleb.
Biophys J 2008; 94: 1836–1853.
2. Charras GT, Yarrow JC, Horton MA, Mahadevan L, Mitchison TJ. Non-equilibration of
hydrostatic pressure in blebbing cells. Nature 2005; 435: 365–369.
3. Charras GT, Hu CK, Coughlin M, Mitchison TJ. Reassembly of contractile actin cortex in
cell blebs. J Cell Biol 2006; 175: 477–490.
4. Croft DR, Coleman ML, Li S, Robertson D, Sullivan T, Stewart CL et al. Actin-myosin-
based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol 2005; 168:
245–255.
5. Orlando KA, Stone NL, Pittman RN. Rho kinase regulates fragmentation and phagocytosis
of apoptotic cells. Exp Cell Res 2006; 312: 5–15.
6. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing
during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001;
3: 339–345.
7. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. Caspase-3-mediated
cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat
Cell Biol 2001; 3: 346–352.
8. Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L et al. Activation of
Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays
an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci USA 2006; 103:
14495–14500.
9. Sebbagh M, Hamelin J, Bertoglio J, Solary E, Breard J. Direct cleavage of II ROCK by
granzyme B induces target cell membrane blebbing in a caspase-independent manner.
J Exp Med 2005; 201: 465–471.
10. Perl M, Denk S, Kalbitz M, Huber-Lang M. Granzyme B: a new crossroad of complement
and apoptosis. Adv Exp Med Biol 2012; 946: 135–146.
11. WitaspE,UthaisangW,Elenstrom-MagnussonC,HanayamaR,TanakaM,NagataSetal.
Bridge over troubled water: milk fat globule epidermal growth factor 8 promotes human
monocyte-derived macrophage clearance of non-blebbing phosphatidylserine-positive
target cells. Cell Death Diff 2007; 14: 1063–1065.
12. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and
disease. J Cell Biol 2010; 189: 1059–1070.
13. Baehrecke EH. How death shapes life during development. Nat Rev Mol Cell Biol 2002; 3:
779–787.
14. KerrJF,WyllieAH,CurrieAR.Apoptosis:abasicbiologicalphenomenonwithwide-ranging
implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.
15. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in
Parkinson’s disease. J Neurol Sci 1996; 137: 120–123.
16. Erwig L-P, Henson PM. Immunological consequences of apoptotic cell phagocytosis.
Am J Path 2007; 171: 2–8.
17. Erwig LP, McPhilips KA, Wynes MW, Ivetic A, Ridley AJ, Henson PM. Differential
regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho
GTPases and ezrin-radixin-moesin (ERM) proteins. Proc Natl Acad Sci USA 2006; 103:
12825–12830.
18. Kinchen JM, Doukoumetzidis K, Almendinger J, Stergiou L, Tosello-Trampont A, Sifri CD
et al. A pathway for phagosome maturation during engulfment of apoptotic cells.
Nat Cell Biol 2008; 10: 556–566.
19. Kinchen JM, Ravichandran KS. Identiﬁcation of two evolutionarily conserved genes
regulating processing of engulfed apoptotic cells. Nature 2010; 464: 778–782.
20. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure,
a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182:
1597–1601.
21. SegawaK,SuzukiJ,NagataS.Constitutiveexposureofphosphatidylserineonviablecells.
Proc Natl Acad Sci USA 2011; 108: 19246–19251.
22. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identiﬁcation of a
factor that links apoptotic cells to phagocytes. Nature 2002; 417: 182–187.
23. Dillon SR, Mancini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and
colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol 2000;
164: 1322–1332.
24. van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, van Heerde WL, Henﬂing ME,
Vermeij-Keers C et al. Transient expression of phosphatidylserine at cell-cell contact areas
is required for myotube formation. J Cell Sci 2001; 114 (Part 20): 3631–3642.
25. Fadeel B. Plasma membrane alterations during apoptosis: role in corpse clearance.
Antioxid Redox Signal 2004; 6: 269–275.
26. Franz S, Herrmann K, Furnrohr BG, Sheriff A, Frey B, Gaipl US et al. After shrinkage
apoptotic cells expose internal membrane-derived epitopes on their plasma membranes.
Cell Death Diff 2007; 14: 733–742.
27. Paidassi H, Tacnet-Delorme P, Verneret M, Gaboriaud C, Houen G, Duus K et al.
Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights
into apoptotic cell recognition. J Mol Biol 2011; 408: 277–290.
28. Orlando KA, Pittman RN. Rho kinase regulates phagocytosis, surface expression
of GlcNAc, and Golgi fragmentation of apoptotic PC12 cells. Exp Cell Res 2006; 312:
3298–3311.
29. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA et al.
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91
initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:
781–795.
30. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed
cell death (apoptosis). Immunology 1985; 56: 351–358.
31. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770–776.
32. Gregory CD. CD14-dependent clearance of apoptotic cells: relevance to the immune
system. Curr Opin Immunol 2000; 12: 27–34.
33. Schagat TL, Wofford JA, Wright JR. Surfactant protein A enhances alveolar macrophage
phagocytosis of apoptotic neutrophils. J Immunol 2001; 166: 2727–2733.
34. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Diff 2008;
15: 243–250.
35. Grimsley C, Ravichandran KS. Cues for apoptotic cell engulfment: eat-me, don’t eat-me
and come-get-me signals. Trends Cell Biol 2003; 13: 648–656.
36. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL et al.
Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes
clearance of apoptotic cells. J Cell Biol 2001; 155: 649–659.
37. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane
microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol
1999; 163: 3801–3811.
38. Korb LC, Ahearn JM. C1q binds directly and speciﬁcally to surface blebs of apoptotic
human keratinocytes: complement deﬁciency and systemic lupus erythematosus revisited.
J Immunol 1997; 158: 4525–4528.
39. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q speciﬁcally
recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 2001; 166:
3231–3239.
40. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance
of apoptotic cells by human macrophages. J Exp Med 1998; 188: 2313–2320.
41. GaiplUS,KuenkeleS,VollRE,BeyerTD,KolowosW,HeyderPetal.Complementbinding
is an early feature of necrotic and a rather late event during apoptotic cell death.
Cell Death Differ 2001; 8: 327–334.
42. Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC et al. The classical and regulatory
functions of C1q in immunity and autoimmunity. Cell Mol Immunol 2008; 5: 9–21.
43. Botto M, Dell’ Agnola C, Bygrave A, Thompson EM, Cook HT, Petry F et al. Homozygous
C1q deﬁciency causes glomerulonephritis associated with multiple apoptotic bodies. Nat
Genet 1998; 19: 56–59.
44. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic
neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol 1992;
52: 269–273.
45. Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of
senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/
thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol
1996; 149: 911–921.
46. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive
effects of apoptotic cells. Nature 1997; 390: 350–351.
47. Poon IKH, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell
clearance. Cell Death Diff 2010; 17: 381–397.
48. Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C.
Early features of apoptosis detected by four different ﬂow cytometry assays. Apoptosis
1998; 3: 115–121.
49. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing
apoptosis. Immunol Today 1993; 14: 131–136.
50. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the
immune arsenal. Nat Rev Immunol 2005; 5: 331–342.
51. Whitacre CC. Sex differences in autoimmune disease. Nature Immunol 2001; 2: 777–780.
52. Gigante A, Gasperini ML, Afeltra A, Barbano B, Margiotta D, Cianci R et al. Cytokines
expression in SLE nephritis. Eur Rev Med Pharmacol Sci 2011; 15: 15–24.
53. Van Bruggen MC, Kramers C, Berden JH. Autoimmunity against nucleosomes and lupus
nephritis. Ann Med Interne 1996; 147: 485–489.
54. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y et al. Autoimmune
disease and impaired uptake of apoptotic cells in MFG-E8-deﬁcient mice. Science 2004;
304: 1147–1150.
55. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired
phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients
with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241–1250.
56. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL et al. Impaired uptake
of apoptotic cells into tingible body macrophages in germinal centers of patients with
systemic lupus erythematosus. Arthritis Rheum 2002; 46: 191–201.
57. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K et al.
Clearance deﬁciency and systemic lupus erythematosus (SLE). J Autoimmun 2007; 28:
114–121.
58. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating
early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus
1998; 7: 113–118.
59. Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz
LK et al. Hereditary C1q deﬁciency and systemic lupus erythematosus. QJM 1994; 87:
455–464.
60. Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in
apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 1998; 5:
183–190.
Apoptotic cell clearance
G Wickman et al
741
Cell Death and Differentiation61. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA
antibodies. Annu Rev Immunol 1994; 12: 487–520.
62. Winkler TH, Fehr H, Kalden JR. Analysis of immunoglobulin variable region genes from
human IgG anti-DNA hybridomas. Eur J Immunol 1992; 22: 1719–1728.
63. FransenJH,vander VlagJ, RubenJ, Adema GJ,Berden JH,HilbrandsLB. Theroleof dendritic
cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther 2010; 12:2 0 7 .
64. Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J et al. Mouse
dendritic cellsmatured byingestionofapoptotic blebsinduce Tcellstoproduce interleukin-
17. Arthrit Rheumat 2009; 60: 2304–2313.
65. SauterB,AlbertML,FranciscoL,LarssonM,SomersanS,BhardwajN.Consequencesofcell
death: exposureto necrotictumor cells,but not primary tissue cells or apoptoticcells,induces
the maturation of immunostimulatory dendritic cells. JE x pM e d2000; 191: 423–434.
66. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells
that have captured apoptotic cells. J Exp Med 2000; 191: 411–416.
67. UrbonaviciuteV,FurnrohrBG,Meister S,MunozL,HeyderP,DeMarchisFetal. Induction
of inﬂammatory and immune responses by HMGB1-nucleosome complexes: implications
for the pathogenesis of SLE. J Exp Med 2008; 205: 3007–3018.
68. Fransen JH, Hilbrands LB, Jacobs CW, Adema GJ, Berden JH, Van der Vlag J. Both early
and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity
2009; 42: 325–327.
69. Suber T, Rosen A. Apoptotic cell blebs: repositories of autoantigens and contributors to
immune context. Arthrit Rheumat 2009; 60: 2216–2219.
70. Frisoni L, McPhie L, Colonna L, Sriram U, Monestier M, Gallucci S et al. Nuclear
autoantigen translocation and autoantibody opsonization lead to increased dendritic cell
phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for
autoimmunity? J Immunol 2005; 175: 2692–2701.
71. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus
erythematosus are clustered in two populations of surface structures on apoptotic
keratinocytes. J Exp Med 1994; 179: 1317–1330.
72. Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM. Autoantigens
are translocated into small apoptotic bodies during early stages of apoptosis.
Cell Death Diff 2008; 15: 183–191.
73. Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA. Mannose-binding lectin-deﬁcient
mice display defective apoptotic cell clearance but no autoimmune phenotype.
J Immunol 2005; 174: 3220–3226.
74. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell
2010; 140: 619–630.
This work is licensed under the Creative Commons
Attribution-NonCommercial-No Derivative Works 3.0
Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/3.0
Apoptotic cell clearance
G Wickman et al
742
Cell Death and Differentiation